MRI shows 'residual echo' from Neanderthals in human brain

Researchers from the National Institute of Mental Health have used MRI to suggest the brain’s ability to use tools and locate objects can be connected to Neanderthal-derived gene variants.

This so-called “residual echo” can be attributed to Neanderthals, who went extinct 40,000 years ago, according to lead researcher Karen Berman, MD. The ancestors of humans interbred with these evolutionary cousins, which resulted in Neanderthal DNA becoming part of the human genome.

“It’s been proposed that Neanderthals depended on visual-spatial abilities and toolmaking, for survival, more so than on the social affiliation and group activities that typify the success of modern humans – and that Neanderthal brains evolved to preferentially support these visuospatial functions,” Berman said. “Now we have direct neuroimaging evidence that such trade-offs may still be operative in our brains.”

The results were published online July 24 through the journal Scientific Reports.

Berman and colleagues examined 221 participants of European ancestry for Neanderthal variants. They then related this to brain structure measured via MRI. The images showed gene variants were likely involved in development of the brain’s visual system.

The team is currently examining what role such genetic information played in brain development.

The full study is available for free here.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.